Sat Nov 1 01:37:38 SGT 2014  
SINGAPORE
SLIMMING™
    Slimming, Singapore (SG)

Slimming, Singapore (SG)

Summary

Slimming, Singapore (SG) @singaporeslimming_com: Medical slimming, weight/fat loss/management/reduction, diet program/medication clinic, Singapore

Description

Join our weight loss program to manage your obesity. For effective slimming and weight management. Choose our weight loss clinic. The weight management clinic with the program that is most likely able to help you achieve your goals.

Aesthetic services available:

Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
SHIM CLINIC
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: Slimming, Singapore (SG)
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.

References


Latest News

Trends in physical activity and sedentary behaviors of U.S. youth - Bassett DR, John D, Conger SA, Fitzhugh EC, Coe DP.
Fri, 31 Oct 2014 08:25:29 +0100 | SafetyLit: All (Unduplicated)
BACKGROUND: Increases in childhood and adolescent obesity are a growing concern in the United States (U.S.), and in most countries throughout the world. Declines in physical activity are often postulated to have contributed to the rise in obesity rates ove... (Source: SafetyLit: All (Unduplicated))

Epidemiology, Risk Factors, Clinical Features, and Outcome of Adult Patients With Severe Pandemic A/H1N1/2009 Influenza in Qatar: A Retrospective Study
Fri, 31 Oct 2014 01:23:51 +0100 | Infectious Diseases in Clinical Practice
ConclusionsMost adult patients admitted with severe pandemic A/H1N1/2009 have one or more risk factors that increase their potential for a severe disease. Clinical features and laboratory finding are nonspecific and are similar to those reported by others, as well as hospital mortality. Being a smoker or having a high Acute Physiology and Chronic Heath Evaluation II score at admission increases the risk of death due to disease. Starting antiviral therapy as early as possible also increases the chance of survival. (Source: Infectious Diseases in Clinical Practice)

Gender assignment in patients with disorder of sex development
Fri, 31 Oct 2014 00:33:33 +0100 | Current Opinion in Endocrinology, Diabetes and Obesity
Purpose of reviewTo examine the sex assignment in patients with atypical external genitalia, a particularly challenging situation, especially when the genital appearance is not compatible with the sex chromosome.

Swyer syndrome
Fri, 31 Oct 2014 00:33:32 +0100 | Current Opinion in Endocrinology, Diabetes and Obesity
Purpose of reviewThis review focuses on the pathogenesis, diagnosis, management and long-term outcomes of disorders of sex development, specifically women with Swyer syndrome (46,XY complete gonadal dysgenesis).

Androgen insensitivity syndrome
Fri, 31 Oct 2014 00:33:31 +0100 | Current Opinion in Endocrinology, Diabetes and Obesity
Purpose of reviewAndrogen insensitivity syndrome (AIS) can present with a wide range of phenotypes, and its management requires a multidisciplinary approach from diagnosis in infancy to adulthood. This review provides an update on some clinical and genetic aspects in AIS. Additional outcome data on surgical and psychosexual findings are presented, together with a discussion on the risk of development of gonadal tumours in AIS.

5α-Reductase inhibitors in androgenetic alopecia
Fri, 31 Oct 2014 00:33:30 +0100 | Current Opinion in Endocrinology, Diabetes and Obesity
Purpose of reviewThe authors will review the current literature on efficacy and safety of 5-alpha reductase inhibitors (5αRIs) for androgenetic alopecia (AGA).

Acromegaly and bone disease
Fri, 31 Oct 2014 00:33:29 +0100 | Current Opinion in Endocrinology, Diabetes and Obesity
Purpose of reviewTo provide an update on current understanding of osteoporosis associated with acromegaly.

5-Alpha reductase deficiency: a 40-year retrospective review
Fri, 31 Oct 2014 00:33:29 +0100 | Current Opinion in Endocrinology, Diabetes and Obesity
This article will review the clinical and molecular history behind the discovery of 5-alpha reductase deficiency.

5-Alpha-reductase inhibitors in diseases of the prostate
Fri, 31 Oct 2014 00:33:29 +0100 | Current Opinion in Endocrinology, Diabetes and Obesity
Purpose of reviewTo summarize the history of the use of 5-alpha-reductase inhibitors in the treatment of urologic diseases and discuss the current practices and indications for therapy.

T-cells and B-cells in osteoporosis
Fri, 31 Oct 2014 00:33:28 +0100 | Current Opinion in Endocrinology, Diabetes and Obesity
Purpose of reviewBone disease is a leading cause of fractures and continues to be a source of significant morbidity and mortality worldwide. As the underlying mechanisms of osteoporosis are elucidated, immune dysfunction continues to emerge as a key precipitating factor in multiple bone disease contexts. This review examines recent findings in the osteoimmunology field and their implications for bone disease and for novel future therapeutic approaches to rejuvenate the skeleton.